Catheter Precision Inc. (VTAK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Catheter Precision Inc. (VTAK) has a cash flow conversion efficiency ratio of -0.227x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.51 Million) by net assets ($6.65 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see VTAK market cap overview for the company's overall valuation and market capitalisation.
Catheter Precision Inc. - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Catheter Precision Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Catheter Precision Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Catheter Precision Inc. ranked by their cash flow conversion efficiency. See Catheter Precision Inc. (VTAK) cash flow to debt to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kiplin Metals Inc
V:KIP
|
-0.072x |
|
Erayak Power Solution Group Inc. Class A Ordinary Shares
NASDAQ:RAYA
|
-0.068x |
|
Gibui Holdings Ltd
TA:GIBUI
|
-0.080x |
|
Cyclerion Therapeutics Inc
NASDAQ:CYCN
|
-0.282x |
|
Crown LNG Holdings Limited Warrants
NASDAQ:CGBSW
|
-0.192x |
|
Cosmo Metals Ltd
AU:CMO
|
-0.018x |
|
Ceylon Graphite Corp
V:CYL
|
1.418x |
|
Oryx International Growth Fund
LSE:OIG
|
0.001x |
Annual Cash Flow Conversion Efficiency for Catheter Precision Inc. (2016–2025)
The table below shows the annual cash flow conversion efficiency of Catheter Precision Inc. from 2016 to 2025. View Catheter Precision Inc. (VTAK) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $6.65 Million | $-8.30 Million | -1.247x | -58.18% |
| 2024-12-31 | $11.76 Million | $-9.27 Million | -0.789x | +18.95% |
| 2023-12-31 | $21.19 Million | $-20.62 Million | -0.973x | +60.08% |
| 2022-12-31 | $9.26 Million | $-22.57 Million | -2.437x | -20.63% |
| 2021-12-31 | $13.67 Million | $-27.62 Million | -2.020x | -50.95% |
| 2020-12-31 | $21.15 Million | $-28.30 Million | -1.338x | -33.75% |
| 2019-12-31 | $33.15 Million | $-33.17 Million | -1.001x | -260.66% |
| 2018-12-31 | $66.70 Million | $-18.51 Million | -0.277x | -138.26% |
| 2017-12-31 | $-7.62 Million | $-5.52 Million | 0.725x | -85.39% |
| 2016-12-31 | $-380.00K | $-1.89 Million | 4.963x | -- |
About Catheter Precision Inc.
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally … Read more